AlphaHunt
Healthcare

BIO Stock Analysis

Bio-Rad Laboratories, Inc. · current price $283.00 (-0.49% today)

★★ Below Avg 48/ Alpha Score
Risk is rising; momentum is fading or fundamentals are weakening. Multiple risk indicators are firing.
LAST EARNINGS Bio-Rad Laboratories, Inc. (BIO)

Latest earnings

EPS
$2.61 vs $1.75 est · +0.5% vs estimate BEAT
Revenue
$592.1M · -9.1% YoY
Stock reaction (1M)
+0.7%
Beat streak
2 of last 4 quarters

Key metrics

Alpha Score
48/100
Grade
D
Rev Growth YoY
+1.1%
30-day Momentum
+0.7%
Forward P/E
47.3×
Analyst Target
$297.00
Implied Upside
+5.0%

Latest news on BIO

Similar stocks in Healthcare

BIIB WST LLY WAT MRNA DGX

View all Healthcare stocks →

BIO — frequently asked

What is BIO's Alpha Score?

Bio-Rad Laboratories, Inc. (BIO) currently has a TickerMover Alpha Score of 48/100, rated ★★ Below Avg. The Alpha Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is Bio-Rad Laboratories, Inc. (BIO) a buy?

TickerMover does not give buy or sell recommendations. BIO scores 48/100 (★★ Below Avg) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is BIO's score updated?

BIO's Alpha Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF, peer comparison and more — free during beta.

Open dashboard for BIO →
TickerMover is a research tool, not financial advice. Alpha Score is a composite signal — always do your own research before investing.
Last updated automatically every 5 minutes during US market hours.
Questions? support@tickermover.com